[The vaccination against measles: effectiveness and care in use (author's transl)].
作者信息
Battistini F D
出版信息
Ann Sclavo. 1979 Jun;21 Suppl 1:394-401.
PMID:42365
Abstract
The A. deals with three clinic aspects of outstanding importance of the measles and its relevant vaccination; that is: the complications of the disease, the contraindications to live virus vaccine and the possible reactions to vaccine. It is particularly stressed the possibility of neurological complications due either to disease or to vaccination posthumous.
摘要
相似文献
1
[The vaccination against measles: effectiveness and care in use (author's transl)].
Ann Sclavo. 1979 Jun;21 Suppl 1:394-401.
2
[Vaccination against measles].[麻疹疫苗接种]
Wien Med Wochenschr. 1974 Mar 16;124(11):166-8.
3
[Complications of measles and antimeasles vaccination].
Ann Pediatr (Paris). 1984 Jun;31(6):477-80.
4
[Epidemiology of measles (author's transl)].
Ann Sclavo. 1979 Jun;21 Suppl 1:384-93.
5
[Measles--atypical course and complications].[麻疹——非典型病程及并发症]
Z Arztl Fortbild (Jena). 1991 Jun 25;85(12):583-5.
6
Incidence of subacute sclerosing panencephalitis following measles and measles vaccination in Japan.日本麻疹及麻疹疫苗接种后亚急性硬化性全脑炎的发病率
Int J Epidemiol. 1989 Sep;18(3):684-9. doi: 10.1093/ije/18.3.684.
7
Measles vaccination and risk of SSPE.麻疹疫苗接种与亚急性硬化性全脑炎风险
Indian Pediatr. 1999 Mar;36(3):317.
8
Epidemiologic studies of measles, measles vaccine, and subacute sclerosing panencephalitis.麻疹、麻疹疫苗与亚急性硬化性全脑炎的流行病学研究
Pediatrics. 1977 Apr;59(4):505-12.
9
[Subacute sclerosing panencephalitis in The Netherlands (1976-1986)].
Ned Tijdschr Geneeskd. 1988 Jun 25;132(26):1194-9.
10
[Prospects of measles and subacute sclerosing panencephalitis (SSPE) elimination in Poland].
Neurol Neurochir Pol. 1999 May-Jun;33(3):653-63.
Zotero 插件